title: Orkambi's Slick Unveiling Puts Insurers in a Bind.
authors.forename: Ed
authors.initials: E
authors.lastname: Silverman
mesh_terms: D000627:Aminophenols / Q000191:economics*; D000631:Aminopyridines / Q000191:economics*; D052117:Benzodioxoles / Q000191:economics*; D003550:Cystic Fibrosis / Q000188:drug therapy; D004338:Drug Combinations; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D019458:Insurance Coverage / Q000191:economics*; D007356:Insurance, Pharmaceutical Services; D015363:Quinolones / Q000191:economics*; D014481:United States
chemical_list: D000627:Aminophenols; D000631:Aminopyridines; D052117:Benzodioxoles; D004338:Drug Combinations; D015363:Quinolones; C000599212:lumacaftor, ivacaftor drug combination